论文部分内容阅读
目的探讨沙美特罗联合丙酸氟替卡松治疗慢性阻塞性肺疾病的临床效果。方法选取我院2011年1月至2013年1月收治的120例慢性阻塞性肺疾病患者进行分组研究,每组60例。对照组患者采用常规治疗,试验组患者在对照组的基础上增加沙美特罗联合丙酸氟替卡松治疗。对两组患者肺功能以及血气分析进行观察和比较。结果临床研究结果显示,试验组患者的肺功能以及血气分析指标改善程度均明显优于对照组,差异有统计学意义(P<0.05)。结论采用沙美特罗联合丙酸氟替卡松对慢性阻塞肺疾病患者进行治疗,效果明显,具有较高的临床应用价值。
Objective To investigate the clinical efficacy of salmeterol combined with fluticasone propionate in the treatment of chronic obstructive pulmonary disease. Methods A total of 120 patients with chronic obstructive pulmonary disease admitted from January 2011 to January 2013 in our hospital were divided into groups, 60 in each. Patients in the control group were treated with conventional therapy. Patients in the test group were treated with salmeterol plus fluticasone propionate on the basis of the control group. Lung function and blood gas analysis were observed and compared between the two groups. Results The results of clinical study showed that the lung function and the improvement of blood gas analysis indexes of patients in the experimental group were significantly better than those in the control group (P <0.05). Conclusion Salmeterol combined with fluticasone propionate in the treatment of patients with chronic obstructive pulmonary disease, the effect is obvious, with high clinical value.